![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 40, 39124-39132, October 3, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



From the Dipartimento di Scienze Farmacologiche, Facoltà di Farmacia, Università degli Studi di Milano, via Balzaretti 9, 20133 Milan, Italy
Bile acid metabolism plays an essential role in cholesterol homeostasis and is critical for the initiation of atherosclerotic disease. However, despite the recent advances, the molecular mechanisms whereby bile acids regulate gene transcription and cholesterol homeostasis in mammals still need further investigations. Here, we show that bile acids suppress transcription of the gene (CYP7A1) encoding cholesterol 7
-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis, also through an unusual mechanism not involving the bile acid nuclear receptor, farnesoid X receptor. By performing cell-based reporter assays, protein/protein interaction, and chromatin immunoprecipitation assays, we demonstrate that bile acids impair the recruitment of peroxisome proliferator-activated receptor-
coactivator-1
and cAMP response element-binding protein-binding protein by hepatocyte nuclear factor-4
, a master regulator of CYP7A1. We also show for the first time that bile acids inhibit transcription of the gene (PEPCK) encoding phosphoenolpyruvate carboxykinase, the rate-limiting enzyme in gluconeogenesis, through the same farnesoid X receptor-independent mechanism. Chromatin immunoprecipitation assay revealed that bile acid-induced dissociation of coactivators from hepatocyte nuclear factor-4
decreased the recruitment of RNA polymerase II to the core promoter and downstream in the 3'-untranslated regions of these two genes, reflecting the reduction of gene transcription. Finally, we found that Cyp7a1 expression was stimulated in fasted mice in parallel to Pepck, whereas the same genes were repressed by bile acids. Collectively, these results reveal a novel regulatory mechanism that controls gene transcription in response to extracellular stimuli and argue that the transcription regulation by bile acids of genes central to cholesterol and glucose metabolism should be viewed dynamically in the context of the fasted-to-fed cycle.
Received for publication, May 14, 2003 , and in revised form, July 8, 2003.
This paper is dedicated to the memory of Professor Giovanni Galli, our mentor and the master who inspired these investigations and kept encouraging us during our careers.
* This work was supported by European Community Grant NORTh QLG1-CT-2001-01513 and Italian Ministry of University and Research Grants COFIN 2002062991 and FIRST 2002 ex MURST 60%. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Both authors contributed equally to this work.
To whom correspondence should be addressed. Tel.: 39-02-503-18393/18323; Fax: 39-02-503-18391; E-mail: Maurizio.Crestani{at}unimi.it.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
N. Ballatori, F. Fang, W. V. Christian, N. Li, and C. L. Hammond Ost{alpha}-Ost{beta} is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver Am J Physiol Gastrointest Liver Physiol, July 1, 2008; 295(1): G179 - G186. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-J. Shin and T. F. Osborne Peroxisome Proliferator-activated Receptor-{gamma} Coactivator-1{alpha} Activation of CYP7A1 during Food Restriction and Diabetes Is Still Inhibited by Small Heterodimer Partner J. Biol. Chem., May 30, 2008; 283(22): 15089 - 15096. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ponugoti, S. Fang, and J. K. Kemper Functional Interaction of Hepatic Nuclear Factor-4 and Peroxisome Proliferator-Activated Receptor-{gamma} Coactivator 1{alpha} in CYP7A1 Regulation Is Inhibited by a Key Lipogenic Activator, Sterol Regulatory Element-Binding Protein-1c Mol. Endocrinol., November 1, 2007; 21(11): 2698 - 2712. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jiang, X. X. Wang, P. Scherzer, P. Wilson, J. Tallman, H. Takahashi, J. Li, M. Iwahashi, E. Sutherland, L. Arend, et al. Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy Diabetes, October 1, 2007; 56(10): 2485 - 2493. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xu, O. L. Tavares-Sanchez, Q. Li, J. Fernando, C. M. Rodriguez, E. J. Studer, W. M. Pandak, P. B. Hylemon, and G. Gil Activation of Bile Acid Biosynthesis by the p38 Mitogen-activated Protein Kinase (MAPK): HEPATOCYTE NUCLEAR FACTOR-4{alpha} PHOSPHORYLATION BY THE p38 MAPK IS REQUIRED FOR CHOLESTEROL 7{alpha}-HYDROXYLASE EXPRESSION J. Biol. Chem., August 24, 2007; 282(34): 24607 - 24614. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pochetti, C. Godio, N. Mitro, D. Caruso, A. Galmozzi, S. Scurati, F. Loiodice, G. Fracchiolla, P. Tortorella, A. Laghezza, et al. Insights into the Mechanism of Partial Agonism: CRYSTAL STRUCTURES OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR {gamma} LIGAND-BINDING DOMAIN IN THE COMPLEX WITH TWO ENANTIOMERIC LIGANDS J. Biol. Chem., June 8, 2007; 282(23): 17314 - 17324. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fang, J. Miao, L. Xiang, B. Ponugoti, E. Treuter, and J. K. Kemper Coordinated Recruitment of Histone Methyltransferase G9a and Other Chromatin-Modifying Enzymes in SHP-Mediated Regulation of Hepatic Bile Acid Metabolism Mol. Cell. Biol., February 15, 2007; 27(4): 1407 - 1424. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Miao, S. Fang, Y. Bae, and J. K. Kemper Functional Inhibitory Cross-talk between Constitutive Androstane Receptor and Hepatic Nuclear Factor-4 in Hepatic Lipid/Glucose Metabolism Is Mediated by Competition for Binding to the DR1 Motif and to the Common Coactivators, GRIP-1 and PGC-1{alpha} J. Biol. Chem., May 26, 2006; 281(21): 14537 - 14546. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rhee, H. Ge, W. Yang, M. Fan, C. Handschin, M. Cooper, J. Lin, C. Li, and B. M. Spiegelman Partnership of PGC-1{alpha} and HNF4{alpha} in the Regulation of Lipoprotein Metabolism J. Biol. Chem., May 26, 2006; 281(21): 14683 - 14690. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Li and J. Y. L. Chiang RIFAMPICIN INDUCTION OF CYP3A4 REQUIRES PREGNANE X RECEPTOR CROSS TALK WITH HEPATOCYTE NUCLEAR FACTOR 4{alpha} AND COACTIVATORS, AND SUPPRESSION OF SMALL HETERODIMER PARTNER GENE EXPRESSION Drug Metab. Dispos., May 1, 2006; 34(5): 756 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zollner, M. Wagner, T. Moustafa, P. Fickert, D. Silbert, J. Gumhold, A. Fuchsbichler, E. Halilbasic, H. Denk, H.-U. Marschall, et al. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-{alpha}/beta in the adaptive response to bile acids Am J Physiol Gastrointest Liver Physiol, May 1, 2006; 290(5): G923 - G932. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Cariou, K. van Harmelen, D. Duran-Sandoval, T. H. van Dijk, A. Grefhorst, M. Abdelkarim, S. Caron, G. Torpier, J.-C. Fruchart, F. J Gonzalez, et al. The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice J. Biol. Chem., April 21, 2006; 281(16): 11039 - 11049. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Song, T. Li, and J. Y. L. Chiang A Prospero-related Homeodomain Protein Is a Novel Co-regulator of Hepatocyte Nuclear Factor 4{alpha} That Regulates the Cholesterol 7{alpha}-Hydroxylase Gene J. Biol. Chem., April 14, 2006; 281(15): 10081 - 10088. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, F. Y. Lee, G. Barrera, H. Lee, C. Vales, F. J. Gonzalez, T. M. Willson, and P. A. Edwards Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice PNAS, January 24, 2006; 103(4): 1006 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Claudel, B. Staels, and F. Kuipers The Farnesoid X Receptor: A Molecular Link Between Bile Acid and Lipid and Glucose Metabolism Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2020 - 2030. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Duran-Sandoval, B. Cariou, F. Percevault, N. Hennuyer, A. Grefhorst, T. H. van Dijk, F. J. Gonzalez, J.-C. Fruchart, F. Kuipers, and B. Staels The Farnesoid X Receptor Modulates Hepatic Carbohydrate Metabolism during the Fasting-Refeeding Transition J. Biol. Chem., August 19, 2005; 280(33): 29971 - 29979. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Popowski, J. J. Eloranta, M. Saborowski, M. Fried, P. J. Meier, and G. A. Kullak-Ublick The Human Organic Anion Transporter 2 Gene Is Transactivated by Hepatocyte Nuclear Factor-4{alpha} and Suppressed by Bile Acids Mol. Pharmacol., May 1, 2005; 67(5): 1629 - 1638. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Cariou, D. Duran-Sandoval, F. Kuipers, and B. Staels Farnesoid X Receptor: A New Player in Glucose Metabolism? Endocrinology, March 1, 2005; 146(3): 981 - 983. [Full Text] [PDF] |
||||
![]() |
K. R. Stayrook, K. S. Bramlett, R. S. Savkur, J. Ficorilli, T. Cook, M. E. Christe, L. F. Michael, and T. P. Burris Regulation of Carbohydrate Metabolism by the Farnesoid X Receptor Endocrinology, March 1, 2005; 146(3): 984 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Honda, G. Salen, Y. Matsuzaki, A. K. Batta, G. Xu, T. Hirayama, G. S. Tint, M. Doy, and S. Shefer Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis J. Lipid Res., February 1, 2005; 46(2): 287 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Corton, U. Apte, S. P. Anderson, P. Limaye, L. Yoon, J. Latendresse, C. Dunn, J. I. Everitt, K. A. Voss, C. Swanson, et al. Mimetics of Caloric Restriction Include Agonists of Lipid-activated Nuclear Receptors J. Biol. Chem., October 29, 2004; 279(44): 46204 - 46212. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bhalla, C. Ozalp, S. Fang, L. Xiang, and J. K. Kemper Ligand-activated Pregnane X Receptor Interferes with HNF-4 Signaling by Targeting a Common Coactivator PGC-1{alpha}: FUNCTIONAL IMPLICATIONS IN HEPATIC CHOLESTEROL AND GLUCOSE METABOLISM J. Biol. Chem., October 22, 2004; 279(43): 45139 - 45147. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamagata, H. Daitoku, Y. Shimamoto, H. Matsuzaki, K. Hirota, J. Ishida, and A. Fukamizu Bile Acids Regulate Gluconeogenic Gene Expression via Small Heterodimer Partner-mediated Repression of Hepatocyte Nuclear Factor 4 and Foxo1 J. Biol. Chem., May 28, 2004; 279(22): 23158 - 23165. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jung, B. Hagenbuch, M. Fried, P. J. Meier, and G. A. Kullak-Ublick Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G752 - G761. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. del Castillo-Olivares, J. A. Campos, W. M. Pandak, and G. Gil The Role of {alpha}1-Fetoprotein Transcription Factor/LRH-1 in Bile Acid Biosynthesis: A KNOWN NUCLEAR RECEPTOR ACTIVATOR THAT CAN ACT AS A SUPPRESSOR OF BILE ACID BIOSYNTHESIS J. Biol. Chem., April 16, 2004; 279(16): 16813 - 16821. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shimamoto, J. Ishida, K. Yamagata, T. Saito, H. Kato, T. Matsuoka, K. Hirota, H. Daitoku, M. Nangaku, K. Yamagata, et al. Inhibitory Effect of the Small Heterodimer Partner on Hepatocyte Nuclear Factor-4 Mediates Bile Acid-induced Repression of the Human Angiotensinogen Gene J. Biol. Chem., February 27, 2004; 279(9): 7770 - 7776. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-J. Shin, J. A. Campos, G. Gil, and T. F. Osborne PGC-1{alpha} Activates CYP7A1 and Bile Acid Biosynthesis J. Biol. Chem., December 12, 2003; 278(50): 50047 - 50052. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |